Gain confidence in your clinical research data with direct data capture (DDC).

Early Phase Experts

As a full-service contract research organization, Southern Star Research has the knowledge, industry relationships and technical expertise to get your early-phase clinical trial up and running safely and efficiently.

With a broad range of experience delivering Phase 1 Healthy Volunteer, First in Human, First in Patient and Phase 2 trials, we know just how important it is for your asset to succeed in the early development lifecycle. Our experienced team will help you obtain high-quality data that will appeal to future investors, meet the requirements of international regulatory bodies such as the FDA, EMA, PMDA, and Health Canada, and prepare your product for larger Phase 3 and 4 studies, partnerships, licensing, and sale.

Whatever your clinical trial needs, we can provide a flexible, bespoke solution that will not only meet your regulatory requirements but also position your product for commercial success.

Bioforum’s clinical research experts have developed an intuitive and easy-to-navigate analytics and visualization platform.
BioGRID brings clinical trial data together in a clear, focused manner to drive smart decision-making processes.

Bioforum’s Clinical Data Management team is fully committed to providing high-quality and reliable services using the industry’s leading technology designed for quality data capture.

A centralized command center for patient randomization and drug supply management—built for today’s complex clinical trials.

What can 22,000 people with an AI-mindset accomplish?

Speed without shortcuts

AI in clinical development at Parexel enables our teams to surface predictive insights at every stage, reducing protocol risk, study delays, and costly trial amendments.

Parexel's approach to AI in clinical development is built on the Precision Pathway, a strategic operating model that embeds AI across the full trial lifecycle. AI empowers our teams at critical decision points to:

1. Simplify complex tasks to accelerate timelines: AI capabilities are delivering up to 50% cycle time reductions in IND submission generation.
2. Apply insights with agility to enable better decision-making
3. Enhance data handling to drive first-time quality through content generation and workflow automation

The Australian Advantage is about saving time and minimizing costs while generating internationally accepted data in preparation for the next Phase.

TrialKit requires minimal training for quick deployment. Its open API integrates seamlessly with databases, ideal for fast patient registry studies and high-quality data.